a methylprednisolone-plus-intravenous immunoglobulin combination therapy for Refractory Kawasaki Disease
Not Applicable
- Conditions
- refractory Kawasaki disease
- Registration Number
- JPRN-UMIN000005022
- Lead Sponsor
- Masahiro Ishii
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
a previous diagnosis, the presence of coronary artery aneurysms, and other contraindications to steroid therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ersistent or recrudescent fever
- Secondary Outcome Measures
Name Time Method